Contract 75H71021P00421
Medtox Diagnostics, Inc. · Department Of Health And Human Services · December 30, 2020
Medtox Diagnostics, Inc. was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on December 30, 2020 for $26,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Crownpoint, NM. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 7, 2025.
Contract details
- PIID
- 75H71021P00421
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Crownpoint, NM
- First action
- December 30, 2020
- Latest action
- December 7, 2025
Description
DEOB/CLOSEOUT
Modification timeline
-
December 7, 2025Mod P00003$-1.2K
-
August 15, 2024Mod P00002DRUGS OF ABUSE TESTING SUPPLIES$1.0K
-
September 17, 2021Mod P00001DRUGS OF ABUSE TESTING SUPPLIES$11.0K
-
December 30, 2020Base awardDRUGS OF ABUSE TESTING SUPPLIES$15.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71021P00421?
Contract 75H71021P00421 is a federal contract awarded to Medtox Diagnostics, Inc. by Department Of Health And Human Services on December 30, 2020 for $26,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75H71021P00421?
Medtox Diagnostics, Inc. won contract 75H71021P00421 from Department Of Health And Human Services.
How much is contract 75H71021P00421 worth?
Contract 75H71021P00421 has obligated $26,000 to date.